Metformin Effects on Bone Metabolism in Type 2 Diabetes
Summary
Type 2 diabetes is accompanied by an increased risk of skeletal fragility that cannot be fully explained by changes in bone mineral density alone. Chronic hyperglycaemia, accumulation of advanced glycation end-products and alterations in bone vascularisation and cell metabolism conspire to compromise bone quality and delay fracture repair. Metformin, a first-line oral hypoglycaemic agent, exerts pleiotropic actions on bone tissue distinct from its glucose-lowering effects. Central to its action is activation of AMP-activated protein kinase (AMPK), a cellular energy sensor that promotes osteogenic gene expression, enhances matrix mineralisation and suppresses fat cell formation within the marrow compartment. Metformin also modulates osteoblast, osteocyte and osteoclast function, shifting the balance towards anabolism by upregulating osteoblast transcription factors such as Runx2, downregulating negative regulators of bone formation and inhibiting osteoclastic resorption. Recent work points to additional benefits in fracture healing through stimulation of specialised bone vasculature and coupling of angiogenesis to osteogenesis. These findings suggest that metformin could serve as an adjunct in the management of diabetic bone disease, with potential to improve skeletal outcomes beyond glycaemic control.
Research from Nature Portfolio
No recent Nature Portfolio content available.
Metformin Effects on Bone Metabolism in Type 2 Diabetes publication trend
The graph below shows the total number of articles in metformin effects on bone metabolism in type 2 diabetes across all publications each year (not limited to Nature Index journals).
Technical terms
Osteoblast: A bone-forming cell responsible for synthesis of bone matrix and mineral deposition.
Osteoclast: A bone-resorbing cell that degrades mineralised matrix during remodelling.
Osteocyte: A mature bone cell embedded within the mineral matrix that regulates bone homeostasis.
Mesenchymal stem cell (MSC): A multipotent progenitor capable of differentiating into osteoblasts, chondrocytes and adipocytes.
AMP-activated protein kinase (AMPK): A central energy sensor kinase that promotes catabolism and supports anabolic processes in low-energy states.
Runx2: A master transcription factor driving osteoblast differentiation and skeletal development.
HIF-1α: Hypoxia-inducible factor 1α, a transcriptional regulator that promotes angiogenesis under low-oxygen conditions.
Type H vessels: A specialised microvascular subtype in bone characterised by high expression of markers that support osteogenesis.
References
- Metformin accelerates bone fracture healing by promoting type H vessel formation through inhibition of YAP1/TAZ expression. Bone Research (2023).
- Improvement of osteogenic differentiation potential of placenta-derived mesenchymal stem cells by metformin via AMPK pathway activation. Stem Cell Research & Therapy (2024).
- The Differential Effect of Metformin on Osteocytes, Osteoblasts, and Osteoclasts. Current Osteoporosis Reports (2023).
About these summaries
This Nature Research Intelligence Topic summary is created with the cited references and a large language model. We take care to ground generated text with facts, and have systems in place to gain human feedback on the overall quality of the process in line with our AI principles. We strive to create accurate and useful summaries for people unfamiliar with the research topic and that supports this goal. These pages are a beta release and will be updated as we learn how best to help people gain value from a research topic summary.
Turn complex research questions into confident strategic decisions
When you're under pressure to set direction, justify investment, or understand your competitive position, you need more than raw data — you need trusted insights you can act on.
Benchmark your performance against global peers using robust, methodologically sound analysis.
Combine quantitative metrics with qualitative expert insight to uncover strengths, gaps and emerging opportunities.
Gain tailored, decision-ready recommendations aligned to your strategic priorities.
Talk to us to learn more about our data dashboards and bespoke strategy reports.
Grow research skills, confidence and careers with training built for every stage of the research lifecycle.
Developed with Nature Portfolio journal Editors and internationally renowned experts. Discover three ways to learn:
Self-paced, online courses in convenient bite-sized units, covering key skills across scientific writing, publishing, grant writing, data analysis, and more.
Expert trainer-led workshops with hands-on exercises and real-time feedback across core research skills, delivered via interactive group sessions.
Editor-led workshops combining core principles in writing and publishing, personalised 1:1 feedback from Nature Portfolio Editors and hands-on exercises.
Explore course catalogues and workshop agendas, enquire about the options or request institutional pricing.